Clinical and Urodynamic Assessment of Bladder Sensation in Multiple Sc
Clinical and Urodynamic Assessment of Bladder Sensation in Multiple Sclerosis
What it found
No result yet.
What was tested
Treatment tested
- Repeated cystometries with bladder sensations assessment
What it measured
Main measures
bladder sensation ( area under the sensation-capacity curve (AUC))
Day 1
Bladder, bowel and sexual functionHow the body handles the medicine
Other measures (1)
bladder sensitivity
Day 1
Bladder, bowel and sexual function
Who could take part
MS (type not specified) · 18 to 99
Show the full criteria
Inclusion criteria
* Age ≥ 18 * MS according to the 2017 Mac Donald diagnostic criteria * Bladder disorders supposedly related to MS * Indication to perform urodynamics * No current medication for bladder disorders * Able to understand and right in French * Affiliated to the "Securite sociale" or "Couverture Medicale Universelle (CMU)", or equivalent organism.
Exclusion criteria
* Legal protection * Pregnancy or breastfeeding mother * MS relapse during the past month * Other associated neurological disease * Genuine stress incontinence related to postpartum * Treatment with antimuscarinics, alpha blockers, beta3 adrenergic, or tibial nerve stimulation in the past 15 days, or with botulinic toxin injection in the past 6 months * Previous lower urinary tract surgery * Inability to use the analogic device due to motor, sensory or ataxic disabilities
As registered. Criteria can change, so ask the trial team or your neurologist.
Contact details on the registryAbout this trial
In the sponsor's words
The aim of the study is to assess the association between bladder sensations progression during bladder filling and severity of Overactive bladder (OAB) in patients with multiple sclerosis.
Loading reviews and guidelines…
History
Started
Feb 2024
Main results due
Feb 2027
Finished
Feb 2027